NAGE logo

NAGE EV/EBITDA

Current (TTM)7.33×
NAGE Quarterly EV/EBITDA (-4480.35× → 161.22×)
High-resolution chart · PNG

NAGE ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc EV/EBITDA — Quarterly
Period endingEV/EBITDA
161.219×
40.0696×
91.8804×
144.8095×
265.1388×
86.6135×
46.7637×
113.4145×
503.2245×
-2,425.4245×
164.9519×
-169.7476×
-52.8605×
-65.346×
-35.1604×
-141.9649×
-17.0903×
-21.1499×
-47.101×
-47.2742×
-123.6182×
-79.9811×
-49.6151×
-61.2582×
-79.1139×
-33.1446×
-28.2487×
-32.4538×
-34.844×
-26.8703×
-20.8815×
-23.192×
-22.0704×
-21.3578×
-32.5486×
-59.9235×
-60.2107×
-62.814×
-62.1597×
-134.7415×
316.4068×
287.0899×
-114.9005×
457.8952×
-1,264.9682×
-169.3505×
-90.0159×
-196.421×
-87.0722×
-108.2175×
-238.3608×
-68.7752×
-83.3913×
-48.5261×
-30.363×
-50.3933×
-15.6536×
-11.8157×
-17.5477×
-24.4011×
-62.744×
-92.4137×
-93.2415×
-102.1277×
-327.0974×
101.2116×
-965.4196×
-164.1282×
-28.1029×
-35.8825×
-61.5614×
-68.9999×
-146.2868×
-21,362.5554×
-17,644.4463×
-14,538.7997×
-21,491.9636×
-4,480.3506×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.